Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they showed promising results in treating femoropopliteal in-stent restenosis in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. Speaking at Vascular Interventional Advances (VIVA) 2022 in Las Vegas (Oct. 31–Nov. 3), Bertges details the benefits of “so-called real-world data,” the “rich repository” of information contained within the VQI, and the virtues of the multispecialty nature of the registry.
